Cargando…

Expression of p53 & epidermal growth factor receptor in glioblastoma

BACKGROUND & OBJECTIVES: Glioblastoma (GB) is the most frequent brain tumour, manifesting at any age, with a peak incidence between 45 and 75 years. Primary and secondary GBs constitute relatively distinct disease entities in evolution, in expression profiles and in therapeutic response. Histopa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karnam, Sameera, Kottu, Radhika, Chowhan, Amit Kumar, Bodepati, Prasad Chandramouleswara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926345/ https://www.ncbi.nlm.nih.gov/pubmed/29664032 http://dx.doi.org/10.4103/ijmr.IJMR_1179_15

Ejemplares similares

p53 mutation and epidermal growth factor receptor overexpression in glioblastoma.
por: Yoon, K. S., et al.
Publicado: (2001)

Human epidermal growth factor receptor 2/neu protein expression in meningiomas: An immunohistochemical study
por: Telugu, Ramesh Babu, et al.
Publicado: (2016)

Hormone receptor status (estrogen receptor, progesterone receptor), human epidermal growth factor-2 and p53 in South Indian breast cancer patients: A tertiary care center experience
por: Patnayak, Rashmi, et al.
Publicado: (2015)

Immunohistochemical study of epidermal growth factor receptor, human epidermal growth factor receptor 2/neu, p53, and Ki67 in oral squamous cell carcinoma
por: Mohanapure, Neelam Sureshrao, et al.
Publicado: (2022)

Epidermal growth factor receptor in glioblastoma
por: Xu, Hongsheng, et al.
Publicado: (2017)

Cutaneous metastasis of transitional cell carcinoma of the urinary bladder: Cytological aspect
por: Narayana, Modugumudi Ananta Satya, et al.
Publicado: (2014)

Vimentin and p53 expression on epidermal growth factor receptor-positive, oestrogen receptor-negative breast carcinomas.
por: Cattoretti, G., et al.
Publicado: (1988)

Assessment of epidermal growth factor receptor status in glioblastomas
por: Zhu, Hui-Jun, et al.
Publicado: (2013)

Anti-Epidermal Growth Factor Receptor Gene Therapy for Glioblastoma
por: Hicks, Martin J., et al.
Publicado: (2016)

Prognostic Impact of Low-Level p53 Expression on Brain Astrocytomas Immunopositive for Epidermal Growth Factor Receptor
por: Tsai, Hung-Pei, et al.
Publicado: (2022)

Expression of p53, Ki67, epidermal growth factor receptor, transforming growth-factorα, and p21 in primary and secondary hyperparathyroidism
por: Paydas, Saime, et al.
Publicado: (2014)

A study of primary glomerular diseases in adults; clinical, histopathological and immunofluorescence correlations
por: Modugumudi, Ananta Satya Narayana, et al.
Publicado: (2015)

Expression of p53, epidermal growth factor receptor, Ki-67 and O(6)-methylguanine-DNA methyltransferase in human gliomas
por: HU, XINHUA, et al.
Publicado: (2013)

Immunohistochemical Evaluation of P53 and Epidermal Growth Factor Receptor Proteins Expression Levels in Gingival Tissue of Opium-dependent Patients
por: Mohammadi, Mohammad, et al.
Publicado: (2017)

Immunohistochemical Detection and Prognostic Significance of p53, Epidermal Growth Factor Receptor, Murine Double Minute 2, and Isocitrate Dehydrogenase 1 in Glioblastoma Multiforme Patients of Pakistan
por: Ali, Syed Muhammad Adnan, et al.
Publicado: (2022)

Molecular Determinants of Glioblastoma Response to Epidermal Growth Factor Receptor Kinase Inhibitors
por: Komotar, Ricardo J., et al.
Publicado: (2008)

Cord Blood Stem Cells Inhibit Epidermal Growth Factor Receptor Translocation to Mitochondria in Glioblastoma
por: Dasari, Venkata Ramesh, et al.
Publicado: (2012)

MDM2 and p53 expression in gliomas: a multivariate survival analysis including proliferation markers and epidermal growth factor receptor.
por: Korkolopoulou, P., et al.
Publicado: (1997)

Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumours.
por: Jaros, E., et al.
Publicado: (1992)

Expression of Human epidermal growth factor receptor 2, Survivin, Enhancer of zeste homolog -2, Cyclooxygenase-2, p53 and p16 molecular markers in Gall bladder carcinoma
por: Gupta, Amit, et al.
Publicado: (2021)

p53 protein expression in human breast carcinoma: relationship to expression of epidermal growth factor receptor, c-erbB-2 protein overexpression, and oestrogen receptor.
por: Poller, D. N., et al.
Publicado: (1992)

Epidermal Growth Factor Receptor Is Related to Poor Survival in Glioblastomas: Single-Institution Experience
por: Choi, Youngmin, et al.
Publicado: (2013)

Expression of mutant p53, c-erbB-2 and the epidermal growth factor receptor in transitional cell carcinoma of the human urinary bladder.
por: Wright, C., et al.
Publicado: (1991)

Oncogenic fingerprint of epidermal growth factor receptor pathway and emerging epidermal growth factor receptor blockade resistance in colorectal cancer
por: Sobani, Zain A, et al.
Publicado: (2016)

Altered expression of the suppressors PML and p53 in glioblastoma cells with the antisense-EGF-receptor
por: Tian, X X, et al.
Publicado: (1999)

Expression of epidermal growth factor receptor, p53, Bcl2, vascular endothelial growth factor, cyclooxygenase-2, cyclin D1, human epidermal receptor-2 and Ki-67: Association with clinicopathological profiles and outcomes in gallbladder carcinoma
por: Doval, Dinesh Chandra, et al.
Publicado: (2014)

Expression and localization of epidermal growth factor, transforming growth factor-α and epidermal growth factor receptor in the canine testis
por: TAMADA, Hiromichi, et al.
Publicado: (2015)

The p53 Pathway in Glioblastoma
por: Zhang, Ying, et al.
Publicado: (2018)

Epidermal Growth Factor Receptor Activation in Glioblastoma through Novel Missense Mutations in the Extracellular Domain
por: Lee, Jeffrey C, et al.
Publicado: (2006)

Activation of Epidermal Growth Factor Receptor Sensitizes Glioblastoma Cells to Hypoxia-Induced Cell Death
por: Luger, Anna-Luisa, et al.
Publicado: (2020)

Epidermal Growth Factor Receptor Expression in the Corneal Epithelium
por: Peterson, Joanne L., et al.
Publicado: (2021)

Addiction of lung cancer cells to GOF p53 is promoted by up-regulation of epidermal growth factor receptor through multiple contacts with p53 transactivation domain and promoter
por: Vaughan, Catherine A., et al.
Publicado: (2016)

Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erbB-2, p53) expression and long-term prognosis.
por: Lipponen, P., et al.
Publicado: (1994)

Expression of transforming growth factor alpha, epidermal growth factor receptor and epidermal growth factor in precursor lesions to gastric carcinoma.
por: Filipe, M. I., et al.
Publicado: (1995)

Ribozyme-Mediated Inhibition of 801-bp Deletion-Mutant Epidermal Growth Factor Receptor mRNA Expression in Glioblastoma Multiforme
por: Karpel-Massler, Georg, et al.
Publicado: (2010)

Synovial sarcoma with relevant immunocytochemistry and special emphasis on the monophasic fibrous variant
por: Kottu, Radhika, et al.
Publicado: (2010)

Epidermal growth factor receptor (EGFR) and EGFRvIII in glioblastoma (GBM): signaling pathways and targeted therapies
por: An, Zhenyi, et al.
Publicado: (2018)

Effects of combined radiosurgery and temozolomide therapy on epidermal growth factor receptor and variant III in glioblastoma multiforme
por: Lin, Yiguang, et al.
Publicado: (2018)

Prediction of regulatory targets of alternative isoforms of the epidermal growth factor receptor in a glioblastoma cell line
por: Weinholdt, Claus, et al.
Publicado: (2019)

The role of erlotinib and the Optune device in a patient with an epidermal growth factor receptor viii amplified glioblastoma
por: Doyle, Sean P, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_bjven1c1tn1q4v4h0if5rppiik